MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development

International Journal of Biochemistry and Cell Biology

Volumn 53, Issue , 2014, Pages 482-492

  Cieśla, Maciej ^a   Dulak, Józef ^a   Józkowicz, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Epigenetic modifications; Heme oxygenase 1; microRNAs; Oxidative stress; Rhabdomyosarcoma

Indexed keywords

MICRORNA; MYOD PROTEIN;

CARCINOGENESIS; CELL DIFFERENTIATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; MUSCLE DEVELOPMENT; OXIDATIVE STRESS; PATHOLOGY; RHABDOMYOSARCOMA;

CARCINOGENESIS; CELL DIFFERENTIATION; EPIGENESIS, GENETIC; HUMANS; MICRORNAS; MUSCLE DEVELOPMENT; MYOD PROTEIN; OXIDATIVE STRESS; RHABDOMYOSARCOMA;

EID: 84905027646     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.05.003     Document Type: Review

References (112)

1. E.H. Ahn Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma Anticancer Res 33 May (5) 2013 2029 2035
2. C.E. Albacker, N.Y. Storer, E.M. Langdon, A. Dibiase, Y. Zhou, and D.M. Langenau et al. The histone methyltransferase SUV39H1 suppresses embryonal rhabdomyosarcoma formation in zebrafish Plos One 8 May (5) 2013 e64969
3. J. Anderson, A. Gordon, K. Pritchard-Jones, and J. Shipley Genes, chromosomes, and rhabdomyosarcoma Genes Chromosomes Cancer 26 December (4) 1999 275 285 (Pubitemid 29529572)
4. S. Armeanu-Ebinger, D. Herrmann, M. Bonin, I. Leuschner, S.W. Warmann, and J. Fuchs et al. Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumour Exp Cell Res 318 December (20) 2012 2567 2577
5. P. Asp, R. Blum, V. Vethantham, F. Parisi, M. Micsinai, and J. Cheng et al. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation Proc Natl Acad Sci USA 108 May (22) 2011 E149 E158
6. S.L. Au, C.C. Wong, J.M. Lee, D.N. Fan, F.H. Tsang, and I.O. Ng et al. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis Hepatology 56 August (2) 2012 622 631
7. N. Bakkar, J. Wang, K.J. Ladner, H. Wang, J.M. Dahlman, and M. Carathers et al. IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis J Cell Biol 180 February (4) 2008 787 802 (Pubitemid 351397778)
8. F.G. Barr, N. Galili, J. Holick, J.A. Biegel, G. Rovera, and B.S. Emanuel Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolarrhabdomyosarcoma Nat Genet 3 February (2) 1993 113 117 (Pubitemid 23079791)
9. P.A. Baeuerle, and D. Baltimore I kappa B: a specific inhibitor of the NF-kappa B transcription factor Science 242 October (4878) 1988 540 546 (Pubitemid 18263193)
10. B.C. Belyea, S. Naini, R.C. Bentley, and C.M. Linardic Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumourigenesis Clin Cancer Res 17 December (23) 2011 7324 7336
11. S. Blein, S. Berndt, A.D. Joshi, D. Campa, R.G. Ziegler, and E. Riboli et al. Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium on Behalf of the NCI Breast and Prostate Cancer Cohort Consortium Free Radic Res January 2014
12. J.M. Blum, L. Añó, Z. Li, D. Van Mater, B.D. Bennett, and M. Sachdeva et al. Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells Cell Rep 5 November (4) 2013 933 940
13. M.F. Buas, S. Kabak, and T. Kadesch The Notch effector Hey1 associates with myogenic target genes to repress myogenesis J Biol Chem 285 January (2) 2010 1249 1258
14. M. Buckingham, and F. Relaix The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions Annu Rev Cell Dev Biol 23 2007 645 673
15. F. Calhabeu, S. Hayashi, J.E. Morgan, F. Relaix, and P.S. Zammit Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells Oncogene 32 January (5) 2013 651 662
16. D.R. Campion The muscle satellite cell: a review Int Rev Cytol 87 1984 225 251 (Pubitemid 14141054)
17. G. Caretti, M. Di Padova, B. Micales, G.E. Lyons, and V. Sartorelli The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation Genes Dev 18 November (21) 2004 2627 2638 (Pubitemid 39453102)
18. A. Casazza, G. Di Conza, M. Wenes, V. Finisguerra, S. Deschoemaeker, and M. Mazzone Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment Oncogene April 2013 10.1038/onc.2013.121
19. J.S. Chamberlain, J. Metzger, M. Reyes, D. Townsend, and J.A. Faulkner Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma FASEB J 21 July (9) 2007 2195 2204 (Pubitemid 47026454)
20. E. Charytonowicz, C. Cordon-Cardo, I. Matushansky, and M. Ziman Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett 279 July (2) 2009 126 136
21. J.F. Chen, E.M. Mandel, J.M. Thomson, Q. Wu, T.E. Callis, and S.M. Hammond et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nat Genet 38 February (2) 2006 228 233 (Pubitemid 43177239)
22. X. Chen, E. Stewart, A.A. Shelat, C. Qu, A. Bahrami, and M. Hatley et al. St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project, Targeting oxidative stress in embryonal rhabdomyosarcoma Cancer Cell 24 December (6) 2013 710 724
23. R. Ciarapica, G. Russo, F. Verginelli, L. Raimondi, A. Donfrancesco, and R. Rota et al. Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma Cell Cycle 8 January (1) 2009 172 175
24. R. Ciarapica, M. De Salvo, E. Carcarino, G. Bracaglia, L. Adesso, and P.P. Leoncini et al. The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx) Oncogene November 2013
25. R. Ciarapica, E. Carcarino, L. Adesso, M. De Salvo, G. Bracaglia, and P.P. Leoncini et al. Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS BMC Cancer 14 February 2014 139
26. M. Ciesla, K. Skrzypek, M. Kozakowska, A. Loboda, A. Jozkowicz, and J. Dulak MicroRNAs as biomarkers of disease onset Anal Bioanal Chem 401 October (7) 2011 2051 2061
27. B. Das, R. Tsuchida, D. Malkin, G. Koren, S. Baruchel, and H. Yeger Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction Stem Cells 26 July (7) 2008 1818 1830
28. B.K. Dey, J. Gagan, and A. Dutta miR-206 and -486 induce myoblast differentiation by downregulating Pax7 Mol Cell Biol 31 January (1) 2011 203 214
29. Y. Diao, X. Guo, L. Jiang, G. Wang, C. Zhang, and J. Wan et al. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in Rhabdomyosarcoma J Biol Chem 289 January (1) 2014 529 539
30. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 April (4) 2006 259 269
31. K.E. Giles, R. Ghirlando, and G. Felsenfeld Maintenance of a constitutive heterochromatin domain in vertebrates by a Dicer-dependent mechanism Nat Cell Biol 12 January (1) 2010 94 99 sup pp. 1-6
32. D.C. Guttridge, M.W. Mayo, L.V. Madrid, C.Y. Wang, and A.S. Baldwin Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia Science 289 September (5488) 2000 2363 2366
33. M.E. Hatley, W. Tang, M.R. Garcia, D. Finkelstein, D.P. Millay, and N. Liu et al. A mouse model of rhabdomyosarcoma originating from the adipocyte lineage Cancer Cell 22 October (4) 2012 536 546
34. A. Hayes-Jordan, and R. Andrassy Rhabdomyosarcoma in children Curr Opin Pediatr 21 June (3) 2009 373 378
35. R.M. Hecker, R.A. Amstutz, M. Wachtel, D. Walter, F.K. Niggli, and B.W. Schäfer p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment Oncogene 29 July (27) 2010 3942 3952
36. J.E. Heredia, L. Mukundan, F.M. Chen, A.A. Mueller, R.C. Deo, and R.M. Locksley et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration Cell 153 April (2) 2013 376 388
37. S. Hettmer, and A.J. Wagers Muscling in: Uncovering the origins of rhabdomyosarcoma Nat Med 16 February (2) 2010 171 173
38. M.S. Ignatius, E. Chen, N.M. Elpek, A.Z. Fuller, I.M. Tenente, and R. Clagg et al. In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma Cancer Cell 21 May (5) 2012 680 693
39. J.S. Imam, K. Buddavarapu, J.S. Lee-Chang, S. Ganapathy, C. Camosy, and Y. Chen et al. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers Oncogene 29 September (35) 2010 4971 4979
40. A.W. Joe, L. Yi, A. Natarajan, F. Le Grand, L. So, and J. Wang et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis Nat Cell Biol 12 February (2) 2010 153 163
41. A. Jozkowicz, H. Was, and J. Dulak Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal 9 December (12) 2007 2099 2117 (Pubitemid 350059009)
42. R.N. Judson, R.H. Zhang, and F.M. Rossi Tissue-resident mesenchymal stem/progenitor cells in skeletal muscle: collaborators or saboteurs? FEBS J 280 September (17) 2013 4100 4108
43. C. Keller, B.R. Arenkiel, C.M. Coffin, N. El-Bardeesy, R.A. DePinho, and M.R. Capecchi Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function Genes Dev 18 November (21) 2004 2614 2626 (Pubitemid 39453101)
44. C. Keller, and M.R. Capecchi New genetic tactics to model alveolar rhabdomyosarcoma in the mouse Cancer Res 65 September (17) 2005 7530 7532 (Pubitemid 41297220)
45. C. Keller, and D.C. Guttridge Mechanisms of impaired differentiation in rhabdomyosarcoma FEBS J 280 September (17) 2013 4323 4334 10.1111/febs.12421
46. K. Kikuchi, A. Soundararajan, L.A. Zarzabal, C.R. Weems, L.D. Nelon, and S.T. Hampton et al. Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma Oncogene 32 January (3) 2013 286 295
47. H.K. Kim, Y.S. Lee, U. Sivaprasad, A. Malhotra, and A. Dutta Muscle-specific microRNA miR-206 promotes muscle differentiation J Cell Biol 174 August (5) 2006 677 687 (Pubitemid 44306724)
48. E. Koscielniak, C. Rodary, F. Flamant, M. Carli, J. Treuner, and C.R. Pinkerton et al. Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis Med Pediatr Oncol 20 3 1992 209 214
49. M. Kozakowska, M. Ciesla, A. Stefanska, K. Skrzypek, H. Was, and A. Jazwa et al. Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs Antioxid Redox Signal 16 January (2) 2012 113 127
50. W. Kuang, J. Tan, Y. Duan, J. Duan, W. Wang, and F. Jin et al. Cyclic stretch induced miR-146a upregulation delays C2C12 myogenic differentiation through inhibition of Numb Biochem Biophys Res Commun 378 January (2) 2009 259 263
51. M.H. Lee, M. Jothi, A.V. Gudkov, and A.K. Mal Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state Cancer Res 71 June (11) 2011 3921 3931
52. L. Lei, S. Mason, D. Liu, Y. Huang, C. Marks, and R. Hickey et al. Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein Mol Cell Biol 28 June (11) 2008 3790 3803 (Pubitemid 351732913)
53. L. Li, A.L. Sarver, S. Alamgir, and S. Subramanian Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma Lab Invest 92 April (4) 2012 571 583
54. Q. Lin, S. Weis, G. Yang, Y.H. Weng, R. Helston, and K. Rish et al. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress J Biol Chem 282 July (28) 2007 20621 20633 (Pubitemid 47100046)
55. M. Liu, Y. Li, L. Chen, T.H. Man Chan, Y. Song, and L. Fu et al. Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma Gastroenterology January 2014 pii: S0016-5085(14)00025-0
56. W. Liu, Y. Wen, P. Bi, X. Lai, X.S. Liu, and X. Liu et al. Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation Development 139 August (16) 2012 2857 2865
57. A. Loboda, H. Was, A. Jozkowicz, and J. Dulak Janus face of Nrf2-HO-1 axis in cancer - friend in chemoprevention, foe in anticancer therapy Lung Cancer 60 April (1) 2008 1 3
58. H. Lu, R.A. Forbes, and A. Verma Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis J Biol Chem 277 June (26) 2002 23111 23115 (Pubitemid 34952134)
59. L. Lu, L. Zhou, E.Z. Chen, K. Sun, P. Jiang, and L. Wang et al. A Novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction ofYY1-miRNA network PLoS One 7 2 2012 e27596
60. K.L. Macquarrie, Z. Yao, J.M. Young, Y. Cao, and S.J. Tapscott miR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells Skelet Muscle 2 April (1) 2012 7
61. T. Mahmoudi, and C.P. Verrijzer Chromatin silencing and activation by Polycomb and trithorax group proteins Oncogene 20 May (24) 2001 3055 3066 (Pubitemid 32553560)
62. S.E. Mahoney, Z. Yao, C.C. Keyes, S.J. Tapscott, and S.J. Diede Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas Epigenetics 7 April (4) 2012 400 408
63. I. Marchesi, A. Giordano, and L. Bagella Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcomacarcinogenesis Cell Cycle 13 February (4) 2014 516 527
64. A. Masià, A. Almazán-Moga, P. Velasco, J. Reventós, N. Torán, and J. Sánchez de Toledo et al. Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cells Br J Cancer 107 October (8) 2012 1374 1383
65. J. Mathieu, Z. Zhang, A. Nelson, D.A. Lamba, T.A. Reh, and C. Ware et al. Hypoxia induces re-entry of committed cells into pluripotency Stem Cells 31 September (9) 2013 1737 1748
66. N. Matsumura, Z. Huang, T. Baba, P.S. Lee, J.C. Barnett, and S. Mori et al. Yin yang 1 modulates taxane response in epithelial ovarian cancer Mol Cancer Res 7 February (2) 2009 210 220
67. S.M. Meadows, A.S. Warkman, M.C. Salanga, E.M. Small, and P.A. Krieg The myocardin-related transcription factor, MASTR, cooperates with MyoD to activate skeletalmuscle gene expression Proc Natl Acad Sci USA 105 February (5) 2008 1545 1550 (Pubitemid 351346551)
68. M. Mimeault, and S.K. Batra Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells J Cell Mol Med 17 January (1) 2013 30 54
69. L. Minai, D. Yeheskely-Hayon, and D. Yelin High levels of reactive oxygen species in gold nanoparticle-targeted cancer cells following femtosecond pulse irradiation Sci Rep 3 2013 2146
70. E. Missiaglia, C.J. Shepherd, S. Patel, K. Thway, G. Pierron, and K. Pritchard-Jones et al. MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas Br J Cancer 102 June (12) 2010 1769 1777
71. E. Missiaglia, D. Williamson, J. Chisholm, P. Wirapati, G. Pierron, and F. Petel et al. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcomaand significantly improves current risk stratification J Clin Oncol 30 May (14) 2012 1670 1677
72. M. Miyachi, K. Tsuchiya, H. Yoshida, S. Yagyu, K. Kikuchi, and A. Misawa et al. Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker forrhabdomyosarcoma Biochem Biophys Res Commun 400 September (1) 2010 89 93
73. S. Nicholson, H. Whitehouse, K. Naidoo, and R.J. Byers Yin Yang 1 in human cancer Crit Rev Oncog 16 3-4 2011 245 260
74. K. Nishijo, Q.R. Chen, L. Zhang, A.T. McCleish, A. Rodriguez, and M.J. Cho et al. Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma Cancer Res 69 April (7) 2009 2902 2911
75. J. Novák, J. Vinklárek, J. Bienertová- Vašků, and O. Slabý MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcomapathogenesis Pediatr Blood Cancer 60 November (11) 2013 1739 1746
76. P. Onyango, and A.P. Feinberg A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript Proc Natl Acad Sci USA 108 October (40) 2011 16759 16764
77. C.M. Penton, J.M. Thomas-Ahner, E.K. Johnson, C. McAllister, and F. Montanaro Muscle side population cells from dystrophic or injured muscle adopt a fibro-adipogenic fate PLoS One 8 1 2013 e54553
78. L. Raimondi, R. Ciarapica, M. De Salvo, F. Verginelli, M. Gueguen, and C. Martini et al. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo Cell Death Differ 19 May (5) 2012 871 881
79. P.K. Rao, R.M. Kumar, M. Farkhondeh, S. Baskerville, and H.F. Lodish Myogenic factors that regulate expression of muscle-specific microRNAs Proc Natl Acad Sci USA 103 June (23) 2006 8721 8726 (Pubitemid 43878086)
80. P.K. Rao, E. Missiaglia, L. Shields, G. Hyde, B. Yuan, and C.J. Shepherd et al. Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells FASEB J 24 September (9) 2010 3427 3437
81. N. Rezai-Zadeh, X. Zhang, F. Namour, G. Fejer, Y.D. Wen, and Y.L. Yao et al. Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1 Genes Dev 17 April (8) 2003 1019 1029 (Pubitemid 36459454)
82. J. Roma, A. Almazán-Moga, J. Sánchez de Toledo, and S. Gallego Notch, wnt, and hedgehog pathways in rhabdomyosarcoma: from single pathways to an integrated network Sarcoma 2012 2012 695603
83. R. Rota, R. Ciarapica, A. Giordano, L. Miele, and F. Locatelli MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality Mol Cancer 10 September 2011 120
84. S. Rossi, E. Stoppani, P.L. Puri, and A. Fanzani Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and extracellular regulated kinase signalling pathways Eur J Cancer 47 May (7) 2011 1095 1105
85. L. Sang, H.A. Coller, and J.M. Roberts Control of the reversibility of cellular quiescence by the transcriptional repressor HES1 Science 321 August (5892) 2008 1095 1100
86. G. Schneider, M.J. Bowser, D.M. Shin, F.G. Barr, and M.Z. Ratajczak The paternally imprinted DLK1-GTL2 locus is differentially methylated in embryonal and alveolar rhabdomyosarcomas Int J Oncol 44 January (1) 2014 295 300
87. J.F. Shern, L. Chen, J. Chmielecki, J.S. Wei, R. Patidar, and M. Rosenberg et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors Cancer Discov 4 February (2) 2014 216 231 10.1158/2159-8290.CD-13-0639
88. N. Shyh-Chang, G.Q. Daley, and L.C. Cantley Stem cell metabolism in tissue development and aging Development 140 June (12) 2013 2535 2547
89. A. Singh, C. Happel, S.K. Manna, G. Acquaah-Mensah, J. Carrerero, and S. Kumar et al. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumourigenesis J Clin Invest 123 July (7) 2013 2921 2934
90. M.M. Sun, J.F. Li, L.L. Guo, H.T. Xiao, L. Dong, and F. Wang et al. TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma Oncogene May 2013
91. R. Taulli, F. Bersani, V. Foglizzo, A. Linari, E. Vigna, and M. Ladanyi et al. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation J Clin Invest 119 August (8) 2009 2366 2378
92. R. Taulli, V. Foglizzo, D. Morena, D.M. Coda, U. Ala, and F. Bersani et al. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma Oncogene June 2013
93. M.M. Thiaville, and J. Kim Oncogenic potential of yin yang 1 mediated through control of imprinted genes Crit Rev Oncog 16 3-4 2011 199 209
94. Z.T. Tong, M.Y. Cai, X.G. Wang, L.L. Kong, S.J. Mai, and Y.H. Liu et al. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin Oncogene 31 February (5) 2012 583 594
95. Z.S. Walters, B. Villarejo-Balcells, D. Olmos, T.W. Buist, E. Missiaglia, and R. Allen et al. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells Oncogene February 2014
96. A.H. Wang, N.R. Bertos, M. Vezmar, N. Pelletier, M. Crosato, and H.H. Heng et al. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor Mol Cell Biol 19 November (11) 1999 7816 7827 (Pubitemid 29493445)
97. H. Wang, R. Garzon, H. Sun, K.J. Ladner, R. Singh, and J. Dahlman et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma Cancer Cell 14 November (5) 2008 369 381
98. D. Williamson, J. Selfe, T. Gordon, Y.J. Lu, K. Pritchard-Jones, and K. Murai et al. Role for amplification and expression of glypican-5 in rhabdomyosarcoma Cancer Res 67 January (1) 2007 57 65 (Pubitemid 46142759)
99. C.E. Winbanks, B. Wang, C. Beyer, P. Koh, L. White, and P. Kantharidis et al. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4 J Biol Chem 286 April (16) 2011 13805 13814
100. C.E. Winbanks, C. Beyer, A. Hagg, H. Qian, P.V. Sepulveda, and P. Gregorevic miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4 PLoS One 8 September (9) 2013 e73589
101. S. Wu, V. Kasim, M.R. Kano, S. Tanaka, S. Ohba, and Y. Miura et al. Transcription factor YY1 contributes to tumor growth by stabilizing hypoxia factor HIF-1α in a p53-independent manner Cancer Res 73 March (6) 2013 1787 1799
102. S.J. van Heeringen, R.C. Akkers, I. van Kruijsbergen, M.A. Arif, L.L. Hanssen, and N. Sharifi et al. Principles of nucleation of H3K27 methylation during embryonic development Genome Res December 2013
103. M. Yamagishi, K. Nakano, A. Miyake, T. Yamochi, Y. Kagami, and A. Tsutsumi et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers Cancer Cell 21 January (1) 2012 121 135
104. D. Yan, E. Dong Xda, X. Chen, L. Wang, C. Lu, and J. Wang et al. MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development J Biol Chem 284 October (43) 2009 29596 29604
105. X. Yan, J. Pan, W. Xiong, M. Cheng, Y. Sun, S. Zhang, and Y. Chen Yin Yang 1 (YY1) synergizes with Smad7 to inhibit TGF-β signaling in the nucleus Sci China Life Sci 57 Jan (1) 2014 128 136
106. H. Yuan, F. Qin, M. Movassagh, H. Park, W. Golden, and Z. Xie et al. A chimeric RNA characteristic of rhabdomyosarcoma in normal myogenesis process Cancer Discov 3 December (12) 2013 1394 1403
107. G. Zardo, A. Ciolfi, L. Vian, L.M. Starnes, M. Billi, and S. Racanicchi et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression Blood. 119 April (17) 2012 4034 4046
108. G. Zardo, A. Ciolfi, L. Vian, M. Billi, S. Racanicchi, and F. Grignani et al. Transcriptional targeting by microRNA-polycomb complexes: a novel route in cell fate determination Cell Cycle 11 October (19) 2012 3543 3549
109. S. Zhang, T. Jiang, L. Feng, J. Sun, H. Lu, and Q. Wang et al. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha J Mol Med (Berl) 90 September (9) 2012 1069 1077
110. X. Zhang, X. Zhao, W. Fiskus, J. Lin, T. Lwin, and R. Rao et al. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas Cancer Cell 22 October (4) 2012 506 523
111. L. Zhou, L. Wang, L. Lu, P. Jiang, H. Sun, and H. Wang A novel target of microRNA-29, Ring1 and YY1-binding protein (Rybp), negatively regulates skeletal myogenesis J Biol Chem 287 July (30) 2012 25255 25265
112. O. Zitka, S. Skalickova, J. Gumulec, M. Masarik, V. Adam, and J. Hubalek et al. Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients Oncol Lett 4 December (6) 2012 1247 1253